nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CA3—pericardium—sarcoma	0.0451	0.103	CbGeAlD
Acetazolamide—AQP1—cartilage tissue—sarcoma	0.0414	0.095	CbGeAlD
Acetazolamide—AQP1—Erythrocytes take up carbon dioxide and release oxygen—HBA1—sarcoma	0.0289	0.319	CbGpPWpGaD
Acetazolamide—Growth retardation—Thiotepa—sarcoma	0.0248	0.0523	CcSEcCtD
Acetazolamide—Growth retardation—Dactinomycin—sarcoma	0.0246	0.0519	CcSEcCtD
Acetazolamide—AQP1—endothelium—sarcoma	0.0218	0.05	CbGeAlD
Acetazolamide—AQP1—mammary gland—sarcoma	0.0176	0.0403	CbGeAlD
Acetazolamide—CA2—periosteum—sarcoma	0.0158	0.0361	CbGeAlD
Acetazolamide—AQP1—myometrium—sarcoma	0.0125	0.0286	CbGeAlD
Acetazolamide—Thrombocytopenic purpura—Thiotepa—sarcoma	0.012	0.0253	CcSEcCtD
Acetazolamide—AQP1—seminal vesicle—sarcoma	0.0113	0.0258	CbGeAlD
Acetazolamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—HBA1—sarcoma	0.0108	0.12	CbGpPWpGaD
Acetazolamide—AQP1—hematopoietic system—sarcoma	0.0107	0.0245	CbGeAlD
Acetazolamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—HBA1—sarcoma	0.0104	0.115	CbGpPWpGaD
Acetazolamide—AQP1—connective tissue—sarcoma	0.0103	0.0236	CbGeAlD
Acetazolamide—Metabolic acidosis—Etoposide—sarcoma	0.0102	0.0216	CcSEcCtD
Acetazolamide—CA1—Erythrocytes take up carbon dioxide and release oxygen—HBA1—sarcoma	0.00997	0.11	CbGpPWpGaD
Acetazolamide—AQP1—smooth muscle tissue—sarcoma	0.00943	0.0216	CbGeAlD
Acetazolamide—AQP1—skin of body—sarcoma	0.00931	0.0213	CbGeAlD
Acetazolamide—CA3—myometrium—sarcoma	0.00914	0.021	CbGeAlD
Acetazolamide—CA5B—mammary gland—sarcoma	0.00819	0.0188	CbGeAlD
Acetazolamide—AQP1—cardiac atrium—sarcoma	0.00813	0.0186	CbGeAlD
Acetazolamide—AQP1—uterus—sarcoma	0.00809	0.0185	CbGeAlD
Acetazolamide—CA3—connective tissue—sarcoma	0.00756	0.0173	CbGeAlD
Acetazolamide—AQP1—lymphoid tissue—sarcoma	0.00754	0.0173	CbGeAlD
Acetazolamide—CA14—seminal vesicle—sarcoma	0.0075	0.0172	CbGeAlD
Acetazolamide—AQP1—tendon—sarcoma	0.00709	0.0162	CbGeAlD
Acetazolamide—Injection site pain—Thiotepa—sarcoma	0.00689	0.0146	CcSEcCtD
Acetazolamide—AQP1—bone marrow—sarcoma	0.00686	0.0157	CbGeAlD
Acetazolamide—CA5A—liver—sarcoma	0.00667	0.0153	CbGeAlD
Acetazolamide—Numbness—Vincristine—sarcoma	0.00601	0.0127	CcSEcCtD
Acetazolamide—CA3—cardiac atrium—sarcoma	0.00596	0.0137	CbGeAlD
Acetazolamide—CA3—uterus—sarcoma	0.00593	0.0136	CbGeAlD
Acetazolamide—AQP1—testis—sarcoma	0.00587	0.0134	CbGeAlD
Acetazolamide—Sensory loss—Vincristine—sarcoma	0.00575	0.0122	CcSEcCtD
Acetazolamide—AQP1—liver—sarcoma	0.00555	0.0127	CbGeAlD
Acetazolamide—CA14—cardiac atrium—sarcoma	0.00541	0.0124	CbGeAlD
Acetazolamide—CA12—connective tissue—sarcoma	0.00535	0.0123	CbGeAlD
Acetazolamide—Aplastic anaemia—Dactinomycin—sarcoma	0.00524	0.0111	CcSEcCtD
Acetazolamide—CA3—tendon—sarcoma	0.0052	0.0119	CbGeAlD
Acetazolamide—CA3—bone marrow—sarcoma	0.00503	0.0115	CbGeAlD
Acetazolamide—Tingling sensation—Etoposide—sarcoma	0.00502	0.0106	CcSEcCtD
Acetazolamide—CA5B—hematopoietic system—sarcoma	0.00499	0.0114	CbGeAlD
Acetazolamide—CA9—tendon—sarcoma	0.00498	0.0114	CbGeAlD
Acetazolamide—Numbness—Etoposide—sarcoma	0.00487	0.0103	CcSEcCtD
Acetazolamide—CA14—tendon—sarcoma	0.00472	0.0108	CbGeAlD
Acetazolamide—Sensory loss—Etoposide—sarcoma	0.00466	0.00985	CcSEcCtD
Acetazolamide—Hepatic failure—Thiotepa—sarcoma	0.00454	0.0096	CcSEcCtD
Acetazolamide—Urine output increased—Vincristine—sarcoma	0.00451	0.00953	CcSEcCtD
Acetazolamide—Hepatic failure—Dactinomycin—sarcoma	0.00451	0.00953	CcSEcCtD
Acetazolamide—CA1—hematopoietic system—sarcoma	0.0044	0.0101	CbGeAlD
Acetazolamide—CA3—testis—sarcoma	0.0043	0.00986	CbGeAlD
Acetazolamide—AQP1—lymph node—sarcoma	0.00425	0.00975	CbGeAlD
Acetazolamide—Polyuria—Vincristine—sarcoma	0.00412	0.00871	CcSEcCtD
Acetazolamide—CA9—testis—sarcoma	0.00412	0.00944	CbGeAlD
Acetazolamide—CA3—liver—sarcoma	0.00407	0.00932	CbGeAlD
Acetazolamide—Hepatic failure—Vincristine—sarcoma	0.00403	0.00851	CcSEcCtD
Acetazolamide—Ataxia—Thiotepa—sarcoma	0.00384	0.00811	CcSEcCtD
Acetazolamide—CA5B—cardiac atrium—sarcoma	0.00379	0.00868	CbGeAlD
Acetazolamide—CA14—liver—sarcoma	0.00369	0.00847	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00365	0.00771	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00364	0.0077	CcSEcCtD
Acetazolamide—Hyponatraemia—Vincristine—sarcoma	0.00363	0.00768	CcSEcCtD
Acetazolamide—CA4—seminal vesicle—sarcoma	0.00362	0.0083	CbGeAlD
Acetazolamide—Hyponatraemia—Mitoxantrone—sarcoma	0.00354	0.00748	CcSEcCtD
Acetazolamide—Ataxia—Vincristine—sarcoma	0.0034	0.00719	CcSEcCtD
Acetazolamide—CA5B—tendon—sarcoma	0.0033	0.00757	CbGeAlD
Acetazolamide—Hypokalaemia—Mitoxantrone—sarcoma	0.00321	0.00678	CcSEcCtD
Acetazolamide—CA2—embryo—sarcoma	0.0032	0.00733	CbGeAlD
Acetazolamide—CA3—lymph node—sarcoma	0.00312	0.00715	CbGeAlD
Acetazolamide—CA1—lymphoid tissue—sarcoma	0.0031	0.00711	CbGeAlD
Acetazolamide—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00309	0.00654	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Etoposide—sarcoma	0.00303	0.0064	CcSEcCtD
Acetazolamide—CA2—seminal vesicle—sarcoma	0.003	0.00688	CbGeAlD
Acetazolamide—Haematuria—Thiotepa—sarcoma	0.003	0.00634	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Thiotepa—sarcoma	0.00297	0.00629	CcSEcCtD
Acetazolamide—Agranulocytosis—Thiotepa—sarcoma	0.00293	0.0062	CcSEcCtD
Acetazolamide—Agranulocytosis—Dactinomycin—sarcoma	0.00291	0.00616	CcSEcCtD
Acetazolamide—CA2—hematopoietic system—sarcoma	0.00285	0.00654	CbGeAlD
Acetazolamide—Photosensitivity reaction—Vincristine—sarcoma	0.00285	0.00603	CcSEcCtD
Acetazolamide—CA1—bone marrow—sarcoma	0.00282	0.00647	CbGeAlD
Acetazolamide—Glycosuria—Epirubicin—sarcoma	0.00279	0.00591	CcSEcCtD
Acetazolamide—Injection site pain—Epirubicin—sarcoma	0.00277	0.00586	CcSEcCtD
Acetazolamide—CA2—connective tissue—sarcoma	0.00275	0.0063	CbGeAlD
Acetazolamide—CA5B—testis—sarcoma	0.00273	0.00626	CbGeAlD
Acetazolamide—Drowsiness—Mitoxantrone—sarcoma	0.00272	0.00574	CcSEcCtD
Acetazolamide—Blood disorder—Epirubicin—sarcoma	0.00271	0.00573	CcSEcCtD
Acetazolamide—Erythema multiforme—Dactinomycin—sarcoma	0.00265	0.0056	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00264	0.00558	CcSEcCtD
Acetazolamide—Tinnitus—Thiotepa—sarcoma	0.00263	0.00556	CcSEcCtD
Acetazolamide—CA4—cardiac atrium—sarcoma	0.00261	0.00599	CbGeAlD
Acetazolamide—Flushing—Dactinomycin—sarcoma	0.0026	0.0055	CcSEcCtD
Acetazolamide—Haematuria—Mitoxantrone—sarcoma	0.00259	0.00547	CcSEcCtD
Acetazolamide—Glycosuria—Doxorubicin—sarcoma	0.00259	0.00546	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Epirubicin—sarcoma	0.00258	0.00544	CcSEcCtD
Acetazolamide—Injection site pain—Doxorubicin—sarcoma	0.00257	0.00542	CcSEcCtD
Acetazolamide—Agranulocytosis—Mitoxantrone—sarcoma	0.00253	0.00536	CcSEcCtD
Acetazolamide—CA2—smooth muscle tissue—sarcoma	0.00251	0.00576	CbGeAlD
Acetazolamide—Blood disorder—Doxorubicin—sarcoma	0.00251	0.0053	CcSEcCtD
Acetazolamide—Hypoaesthesia—Vincristine—sarcoma	0.00249	0.00526	CcSEcCtD
Acetazolamide—CA2—skin of body—sarcoma	0.00248	0.00569	CbGeAlD
Acetazolamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—sarcoma	0.00242	0.0267	CbGpPWpGaD
Acetazolamide—Jaundice cholestatic—Doxorubicin—sarcoma	0.00238	0.00504	CcSEcCtD
Acetazolamide—CA1—liver—sarcoma	0.00228	0.00523	CbGeAlD
Acetazolamide—CA4—tendon—sarcoma	0.00228	0.00522	CbGeAlD
Acetazolamide—Ill-defined disorder—Dactinomycin—sarcoma	0.00226	0.00478	CcSEcCtD
Acetazolamide—Agitation—Thiotepa—sarcoma	0.00226	0.00477	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00224	0.00473	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—sarcoma	0.00221	0.00467	CcSEcCtD
Acetazolamide—CA4—bone marrow—sarcoma	0.00221	0.00506	CbGeAlD
Acetazolamide—Leukopenia—Thiotepa—sarcoma	0.0022	0.00465	CcSEcCtD
Acetazolamide—Malaise—Dactinomycin—sarcoma	0.0022	0.00465	CcSEcCtD
Acetazolamide—Leukopenia—Dactinomycin—sarcoma	0.00218	0.00461	CcSEcCtD
Acetazolamide—CA2—cardiac atrium—sarcoma	0.00217	0.00497	CbGeAlD
Acetazolamide—Hepatobiliary disease—Etoposide—sarcoma	0.00214	0.00452	CcSEcCtD
Acetazolamide—Convulsion—Thiotepa—sarcoma	0.00213	0.0045	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—sarcoma	0.00213	0.00449	CcSEcCtD
Acetazolamide—Agranulocytosis—Etoposide—sarcoma	0.00211	0.00446	CcSEcCtD
Acetazolamide—Dysgeusia—Mitoxantrone—sarcoma	0.00208	0.00439	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.00207	0.0228	CbGpPWpGaD
Acetazolamide—Discomfort—Dactinomycin—sarcoma	0.00205	0.00434	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—sarcoma	0.00205	0.00432	CcSEcCtD
Acetazolamide—Confusional state—Thiotepa—sarcoma	0.00202	0.00427	CcSEcCtD
Acetazolamide—Hypoaesthesia—Etoposide—sarcoma	0.00202	0.00426	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—MYOD1—sarcoma	0.00201	0.0222	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CD34—sarcoma	0.00201	0.0222	CbGpPWpGaD
Acetazolamide—CA2—lymphoid tissue—sarcoma	0.00201	0.00461	CbGeAlD
Acetazolamide—Agitation—Vincristine—sarcoma	0.002	0.00423	CcSEcCtD
Acetazolamide—CA5B—lymph node—sarcoma	0.00198	0.00454	CbGeAlD
Acetazolamide—Ill-defined disorder—Mitoxantrone—sarcoma	0.00197	0.00416	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—sarcoma	0.00197	0.00416	CcSEcCtD
Acetazolamide—Thrombocytopenia—Thiotepa—sarcoma	0.00196	0.00415	CcSEcCtD
Acetazolamide—Leukopenia—Vincristine—sarcoma	0.00195	0.00412	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dactinomycin—sarcoma	0.00195	0.00412	CcSEcCtD
Acetazolamide—Erythema multiforme—Etoposide—sarcoma	0.00192	0.00405	CcSEcCtD
Acetazolamide—Malaise—Mitoxantrone—sarcoma	0.00191	0.00405	CcSEcCtD
Acetazolamide—Leukopenia—Mitoxantrone—sarcoma	0.0019	0.00402	CcSEcCtD
Acetazolamide—CA2—tendon—sarcoma	0.00189	0.00433	CbGeAlD
Acetazolamide—Convulsion—Vincristine—sarcoma	0.00189	0.00399	CcSEcCtD
Acetazolamide—CA4—testis—sarcoma	0.00189	0.00432	CbGeAlD
Acetazolamide—Flushing—Etoposide—sarcoma	0.00188	0.00398	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—sarcoma	0.00188	0.00397	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—sarcoma	0.00187	0.00396	CcSEcCtD
Acetazolamide—CYP3A4—hematopoietic system—sarcoma	0.00184	0.00422	CbGeAlD
Acetazolamide—Convulsion—Mitoxantrone—sarcoma	0.00184	0.00389	CcSEcCtD
Acetazolamide—CA2—bone marrow—sarcoma	0.00183	0.00419	CbGeAlD
Acetazolamide—Hepatic failure—Epirubicin—sarcoma	0.00183	0.00386	CcSEcCtD
Acetazolamide—Paraesthesia—Thiotepa—sarcoma	0.0018	0.00381	CcSEcCtD
Acetazolamide—Discomfort—Mitoxantrone—sarcoma	0.00179	0.00377	CcSEcCtD
Acetazolamide—Somnolence—Thiotepa—sarcoma	0.00178	0.00377	CcSEcCtD
Acetazolamide—Anaphylactic shock—Vincristine—sarcoma	0.00178	0.00376	CcSEcCtD
Acetazolamide—Dyspepsia—Thiotepa—sarcoma	0.00177	0.00373	CcSEcCtD
Acetazolamide—CA1—lymph node—sarcoma	0.00175	0.00401	CbGeAlD
Acetazolamide—Confusional state—Mitoxantrone—sarcoma	0.00175	0.00369	CcSEcCtD
Acetazolamide—Decreased appetite—Thiotepa—sarcoma	0.00174	0.00369	CcSEcCtD
Acetazolamide—Thrombocytopenia—Vincristine—sarcoma	0.00174	0.00368	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—sarcoma	0.00174	0.00368	CcSEcCtD
Acetazolamide—Anaphylactic shock—Mitoxantrone—sarcoma	0.00173	0.00366	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Thiotepa—sarcoma	0.00173	0.00366	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—sarcoma	0.00173	0.00366	CcSEcCtD
Acetazolamide—Decreased appetite—Dactinomycin—sarcoma	0.00173	0.00366	CcSEcCtD
Acetazolamide—Fatigue—Thiotepa—sarcoma	0.00173	0.00365	CcSEcCtD
Acetazolamide—Dysgeusia—Etoposide—sarcoma	0.00173	0.00365	CcSEcCtD
Acetazolamide—Fatigue—Dactinomycin—sarcoma	0.00172	0.00363	CcSEcCtD
Acetazolamide—Shock—Mitoxantrone—sarcoma	0.0017	0.0036	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—sarcoma	0.0017	0.00359	CcSEcCtD
Acetazolamide—Thrombocytopenia—Mitoxantrone—sarcoma	0.0017	0.00358	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—sarcoma	0.00169	0.00358	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—sarcoma	0.00168	0.00356	CcSEcCtD
Acetazolamide—Feeling abnormal—Thiotepa—sarcoma	0.00165	0.00349	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—sarcoma	0.00165	0.00349	CcSEcCtD
Acetazolamide—Feeling abnormal—Dactinomycin—sarcoma	0.00164	0.00347	CcSEcCtD
Acetazolamide—Ill-defined disorder—Etoposide—sarcoma	0.00164	0.00346	CcSEcCtD
Acetazolamide—Paraesthesia—Vincristine—sarcoma	0.0016	0.00338	CcSEcCtD
Acetazolamide—Urticaria—Thiotepa—sarcoma	0.00159	0.00337	CcSEcCtD
Acetazolamide—Malaise—Etoposide—sarcoma	0.00159	0.00336	CcSEcCtD
Acetazolamide—Body temperature increased—Thiotepa—sarcoma	0.00159	0.00335	CcSEcCtD
Acetazolamide—Leukopenia—Etoposide—sarcoma	0.00158	0.00334	CcSEcCtD
Acetazolamide—Body temperature increased—Dactinomycin—sarcoma	0.00157	0.00333	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00157	0.00332	CcSEcCtD
Acetazolamide—CA2—testis—sarcoma	0.00156	0.00359	CbGeAlD
Acetazolamide—Hypoglycaemia—Doxorubicin—sarcoma	0.00156	0.00329	CcSEcCtD
Acetazolamide—Paraesthesia—Mitoxantrone—sarcoma	0.00156	0.00329	CcSEcCtD
Acetazolamide—Decreased appetite—Vincristine—sarcoma	0.00155	0.00327	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—sarcoma	0.00154	0.00327	CcSEcCtD
Acetazolamide—Somnolence—Mitoxantrone—sarcoma	0.00154	0.00325	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vincristine—sarcoma	0.00154	0.00325	CcSEcCtD
Acetazolamide—Fatigue—Vincristine—sarcoma	0.00153	0.00324	CcSEcCtD
Acetazolamide—Convulsion—Etoposide—sarcoma	0.00153	0.00323	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—sarcoma	0.00153	0.00323	CcSEcCtD
Acetazolamide—Dyspepsia—Mitoxantrone—sarcoma	0.00152	0.00322	CcSEcCtD
Acetazolamide—Decreased appetite—Mitoxantrone—sarcoma	0.00151	0.00318	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—sarcoma	0.0015	0.00316	CcSEcCtD
Acetazolamide—Fatigue—Mitoxantrone—sarcoma	0.00149	0.00316	CcSEcCtD
Acetazolamide—Discomfort—Etoposide—sarcoma	0.00148	0.00314	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00148	0.00313	CcSEcCtD
Acetazolamide—CA2—liver—sarcoma	0.00148	0.00339	CbGeAlD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.00146	0.0161	CbGpPWpGaD
Acetazolamide—Confusional state—Etoposide—sarcoma	0.00145	0.00307	CcSEcCtD
Acetazolamide—Anaphylactic shock—Etoposide—sarcoma	0.00144	0.00305	CcSEcCtD
Acetazolamide—Asthenia—Thiotepa—sarcoma	0.00144	0.00304	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—sarcoma	0.00143	0.00302	CcSEcCtD
Acetazolamide—Asthenia—Dactinomycin—sarcoma	0.00143	0.00302	CcSEcCtD
Acetazolamide—Feeling abnormal—Mitoxantrone—sarcoma	0.00143	0.00302	CcSEcCtD
Acetazolamide—Thrombocytopenia—Etoposide—sarcoma	0.00141	0.00298	CcSEcCtD
Acetazolamide—Body temperature increased—Vincristine—sarcoma	0.00141	0.00297	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—sarcoma	0.00138	0.00292	CcSEcCtD
Acetazolamide—Urticaria—Mitoxantrone—sarcoma	0.00138	0.00291	CcSEcCtD
Acetazolamide—Diarrhoea—Thiotepa—sarcoma	0.00137	0.0029	CcSEcCtD
Acetazolamide—Body temperature increased—Mitoxantrone—sarcoma	0.00137	0.00289	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00137	0.00289	CcSEcCtD
Acetazolamide—CA4—lymph node—sarcoma	0.00137	0.00313	CbGeAlD
Acetazolamide—Diarrhoea—Dactinomycin—sarcoma	0.00136	0.00288	CcSEcCtD
Acetazolamide—Dizziness—Thiotepa—sarcoma	0.00133	0.0028	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—sarcoma	0.0013	0.00274	CcSEcCtD
Acetazolamide—Paraesthesia—Etoposide—sarcoma	0.00129	0.00273	CcSEcCtD
Acetazolamide—Somnolence—Etoposide—sarcoma	0.00128	0.00271	CcSEcCtD
Acetazolamide—Asthenia—Vincristine—sarcoma	0.00128	0.0027	CcSEcCtD
Acetazolamide—Vomiting—Thiotepa—sarcoma	0.00128	0.0027	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—sarcoma	0.00127	0.00268	CcSEcCtD
Acetazolamide—Vomiting—Dactinomycin—sarcoma	0.00127	0.00268	CcSEcCtD
Acetazolamide—Headache—Thiotepa—sarcoma	0.00126	0.00266	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00126	0.00265	CcSEcCtD
Acetazolamide—Decreased appetite—Etoposide—sarcoma	0.00125	0.00265	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Etoposide—sarcoma	0.00124	0.00263	CcSEcCtD
Acetazolamide—Asthenia—Mitoxantrone—sarcoma	0.00124	0.00263	CcSEcCtD
Acetazolamide—Fatigue—Etoposide—sarcoma	0.00124	0.00263	CcSEcCtD
Acetazolamide—Diarrhoea—Vincristine—sarcoma	0.00122	0.00257	CcSEcCtD
Acetazolamide—Haematuria—Epirubicin—sarcoma	0.00121	0.00255	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—sarcoma	0.0012	0.00254	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—sarcoma	0.0012	0.00253	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—IL2—sarcoma	0.0012	0.0132	CbGpPWpGaD
Acetazolamide—Nausea—Thiotepa—sarcoma	0.00119	0.00252	CcSEcCtD
Acetazolamide—Feeling abnormal—Etoposide—sarcoma	0.00119	0.00251	CcSEcCtD
Acetazolamide—Diarrhoea—Mitoxantrone—sarcoma	0.00119	0.0025	CcSEcCtD
Acetazolamide—Nausea—Dactinomycin—sarcoma	0.00118	0.0025	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—sarcoma	0.00118	0.0025	CcSEcCtD
Acetazolamide—Dizziness—Vincristine—sarcoma	0.00118	0.00249	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—sarcoma	0.00117	0.00248	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—CCND1—sarcoma	0.00117	0.0129	CbGpPWpGaD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00116	0.00246	CcSEcCtD
Acetazolamide—Urticaria—Etoposide—sarcoma	0.00114	0.00242	CcSEcCtD
Acetazolamide—Body temperature increased—Etoposide—sarcoma	0.00114	0.00241	CcSEcCtD
Acetazolamide—CA2—lymph node—sarcoma	0.00113	0.0026	CbGeAlD
Acetazolamide—Hypoaesthesia—Epirubicin—sarcoma	0.00113	0.00239	CcSEcCtD
Acetazolamide—Vomiting—Vincristine—sarcoma	0.00113	0.00239	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—sarcoma	0.00112	0.00236	CcSEcCtD
Acetazolamide—Headache—Vincristine—sarcoma	0.00111	0.00235	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—sarcoma	0.00111	0.00234	CcSEcCtD
Acetazolamide—Vomiting—Mitoxantrone—sarcoma	0.0011	0.00233	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—sarcoma	0.00109	0.00231	CcSEcCtD
Acetazolamide—Headache—Mitoxantrone—sarcoma	0.00109	0.00229	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—sarcoma	0.00107	0.00227	CcSEcCtD
Acetazolamide—CA9—Cellular response to hypoxia—VEGFA—sarcoma	0.00107	0.0118	CbGpPWpGaD
Acetazolamide—Tinnitus—Epirubicin—sarcoma	0.00106	0.00224	CcSEcCtD
Acetazolamide—Nausea—Vincristine—sarcoma	0.00106	0.00223	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—sarcoma	0.00105	0.00223	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—sarcoma	0.00105	0.00221	CcSEcCtD
Acetazolamide—Asthenia—Etoposide—sarcoma	0.00103	0.00218	CcSEcCtD
Acetazolamide—Nausea—Mitoxantrone—sarcoma	0.00103	0.00217	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—sarcoma	0.000994	0.0021	CcSEcCtD
Acetazolamide—Diarrhoea—Etoposide—sarcoma	0.000986	0.00208	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—sarcoma	0.000981	0.00207	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—sarcoma	0.000976	0.00206	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—sarcoma	0.000969	0.00205	CcSEcCtD
Acetazolamide—CYP3A4—liver—sarcoma	0.000954	0.00219	CbGeAlD
Acetazolamide—Dizziness—Etoposide—sarcoma	0.000953	0.00201	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—MYC—sarcoma	0.000936	0.0103	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Epirubicin—sarcoma	0.000918	0.00194	CcSEcCtD
Acetazolamide—Vomiting—Etoposide—sarcoma	0.000916	0.00194	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—EGFR—sarcoma	0.000915	0.0101	CbGpPWpGaD
Acetazolamide—Agitation—Epirubicin—sarcoma	0.000909	0.00192	CcSEcCtD
Acetazolamide—Headache—Etoposide—sarcoma	0.000903	0.00191	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—sarcoma	0.000897	0.0019	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—sarcoma	0.000892	0.00189	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—sarcoma	0.000886	0.00187	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—sarcoma	0.000857	0.00181	CcSEcCtD
Acetazolamide—Nausea—Etoposide—sarcoma	0.000856	0.00181	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—sarcoma	0.000849	0.0018	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—sarcoma	0.000841	0.00178	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—sarcoma	0.000832	0.00176	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—sarcoma	0.000826	0.00175	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—sarcoma	0.00082	0.00173	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—sarcoma	0.000814	0.00172	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—sarcoma	0.000808	0.00171	CcSEcCtD
Acetazolamide—Shock—Epirubicin—sarcoma	0.000795	0.00168	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—sarcoma	0.000793	0.00168	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—sarcoma	0.000791	0.00167	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000782	0.00864	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—KIT—sarcoma	0.000771	0.00851	CbGpPWpGaD
Acetazolamide—Discomfort—Doxorubicin—sarcoma	0.00077	0.00163	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—TP53—sarcoma	0.000769	0.00849	CbGpPWpGaD
Acetazolamide—Confusional state—Doxorubicin—sarcoma	0.000753	0.00159	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—sarcoma	0.000747	0.00158	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—sarcoma	0.000735	0.00155	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—sarcoma	0.000732	0.00155	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—sarcoma	0.000725	0.00153	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—sarcoma	0.000718	0.00152	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—sarcoma	0.000711	0.0015	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—sarcoma	0.000702	0.00148	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000697	0.00147	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—sarcoma	0.000696	0.00147	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—sarcoma	0.000671	0.00142	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—sarcoma	0.000665	0.00141	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—sarcoma	0.000664	0.0014	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—sarcoma	0.000658	0.00139	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—sarcoma	0.00065	0.00137	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000645	0.00136	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—sarcoma	0.000644	0.00136	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—sarcoma	0.000642	0.00136	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—sarcoma	0.000638	0.00135	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—sarcoma	0.000616	0.0013	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—sarcoma	0.000594	0.00125	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—sarcoma	0.000591	0.00125	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—sarcoma	0.000579	0.00122	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000562	0.00621	CbGpPWpGaD
Acetazolamide—Diarrhoea—Epirubicin—sarcoma	0.000553	0.00117	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—sarcoma	0.000536	0.00113	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—sarcoma	0.000534	0.00113	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—CCND1—sarcoma	0.000529	0.00584	CbGpPWpGaD
Acetazolamide—Vomiting—Epirubicin—sarcoma	0.000513	0.00109	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—sarcoma	0.000511	0.00108	CcSEcCtD
Acetazolamide—Headache—Epirubicin—sarcoma	0.000506	0.00107	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—sarcoma	0.000494	0.00104	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000491	0.00543	CbGpPWpGaD
Acetazolamide—Nausea—Epirubicin—sarcoma	0.00048	0.00101	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—sarcoma	0.000475	0.001	CcSEcCtD
Acetazolamide—AQP1—Metabolism—ENO2—sarcoma	0.000469	0.00518	CbGpPWpGaD
Acetazolamide—Headache—Doxorubicin—sarcoma	0.000468	0.000989	CcSEcCtD
Acetazolamide—AQP1—Metabolism—HBA1—sarcoma	0.000466	0.00515	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—NRAS—sarcoma	0.000455	0.00503	CbGpPWpGaD
Acetazolamide—Nausea—Doxorubicin—sarcoma	0.000444	0.000938	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—MYC—sarcoma	0.000424	0.00468	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ENO2—sarcoma	0.000407	0.00449	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—HBA1—sarcoma	0.000404	0.00446	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PLCG1—sarcoma	0.000398	0.00439	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—KRAS—sarcoma	0.000392	0.00433	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PLCG1—sarcoma	0.000345	0.00381	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—HRAS—sarcoma	0.000333	0.00368	CbGpPWpGaD
Acetazolamide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000324	0.00358	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ENO2—sarcoma	0.000262	0.00289	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—HBA1—sarcoma	0.00026	0.00288	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ENO2—sarcoma	0.000255	0.00282	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ENO2—sarcoma	0.000255	0.00282	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—HBA1—sarcoma	0.000254	0.0028	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—HBA1—sarcoma	0.000254	0.0028	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ENO2—sarcoma	0.000238	0.00263	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ENO2—sarcoma	0.000238	0.00263	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—HBA1—sarcoma	0.000237	0.00262	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—HBA1—sarcoma	0.000237	0.00262	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PLCG1—sarcoma	0.000222	0.00246	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ENO2—sarcoma	0.000221	0.00244	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HBA1—sarcoma	0.000219	0.00242	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PLCG1—sarcoma	0.000217	0.00239	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PLCG1—sarcoma	0.000217	0.00239	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MDM2—sarcoma	0.000213	0.00236	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PLCG1—sarcoma	0.000202	0.00223	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PLCG1—sarcoma	0.000202	0.00223	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PLCG1—sarcoma	0.000187	0.00207	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—JUN—sarcoma	0.000186	0.00205	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ENO2—sarcoma	0.000176	0.00195	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HBA1—sarcoma	0.000175	0.00193	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ENO2—sarcoma	0.000169	0.00186	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HBA1—sarcoma	0.000168	0.00185	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—sarcoma	0.000162	0.00179	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ENO2—sarcoma	0.000162	0.00179	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HBA1—sarcoma	0.000161	0.00178	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PLCG1—sarcoma	0.000149	0.00165	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000145	0.00161	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PLCG1—sarcoma	0.000143	0.00158	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ENO2—sarcoma	0.000142	0.00157	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HBA1—sarcoma	0.000141	0.00156	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PLCG1—sarcoma	0.000137	0.00152	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—sarcoma	0.000122	0.00135	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PLCG1—sarcoma	0.000121	0.00133	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ENO2—sarcoma	2.4e-05	0.000265	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HBA1—sarcoma	2.38e-05	0.000263	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLCG1—sarcoma	2.03e-05	0.000224	CbGpPWpGaD
